Allogeneic haematopoietic stem cell transplantation (HSCT) for juvenile myelomonocytic leukaemia (JMML) in France: a retrospective study of Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

被引:0
|
作者
Meyran, D. [1 ]
Porcher, R. [2 ]
Raus, N. [3 ]
Strullu, M. [4 ]
Ouache, M. [1 ]
Yakouben, K. [1 ]
Galambrun, C. [5 ]
Neven, B. [6 ]
Lutz, P. [7 ]
Cave, H. [1 ]
Dalle, J-H. [1 ]
机构
[1] Hop Robert Debre, F-75019 Paris, France
[2] Hop St Louis, Paris, France
[3] Hop Edouard Herriot, Lyon, France
[4] CHU Nantes, F-44035 Nantes 01, France
[5] Hop Enfants La Timone, Marseille, France
[6] Hop Necker Enfants Malad, Paris, France
[7] CHRU Strasbourg, Strasbourg, France
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S53 / S53
页数:1
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation for peripheral T-cell lymphomas: a study of 284 patients from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire
    Mamez, Anne-Claire
    SWISS MEDICAL WEEKLY, 2018, 148 : 10S - 10S
  • [22] Allogeneic stem cell tranplantation for adult patients with active refractory/relapsed haematological malignancies: a survey from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Chevallier, P.
    Milpied, N.
    Bilger, K.
    Socie, G.
    Yakoub-Agha, I.
    Michallet, M.
    Cahn, J. Y.
    Beguin, Y.
    Bay, J. O.
    Blaise, D.
    Guilhot, F.
    Berthou, C.
    Deconinck, E.
    Raus, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S47 - S47
  • [23] Therapeutic management of patients relapsing after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome: a large-scale study on behalf of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Guieze, R.
    Damaj, G.
    Robin, M.
    Mohty, M.
    Michallet, M.
    Tabrizi, R.
    Beguin, Y.
    Blaise, D.
    Roosweil, D.
    Bulabois, C. -E.
    Legrand, F.
    Huynh, A.
    Cornillon, J.
    Contentin, N.
    Suarez, F.
    Lioure, B.
    Maillard, N.
    Clement, L.
    Guillerm, G.
    Rubio, M. -T.
    Garnier, F.
    Yakoub-Agha, I.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S16 - S17
  • [24] Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Mamez, Anne-Claire
    Dupont, Axelle
    Blaise, Didier
    Chevallier, Patrice
    Forcade, Edouard
    Ceballos, Patrice
    Mohty, Mohamad
    Suarez, Felipe
    Beguin, Yves
    De Latour, Regis Peffault
    Rubio, Marie-Therese
    Tournilhac, Olivier
    Nguyen, Stephanie
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [25] Central nervous system involvement in adult acute lymphoblastic leukaemia at diagnosis treated with autologous and allogeneic transplantation: a survey from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Chantepie, S. P.
    Mohty, M.
    Tabrizi, R.
    Socie, G.
    Deconinck, E.
    Buzyn, A.
    Contentin, N.
    Raus, N.
    Lheritier, V.
    Reman, O.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S270 - S270
  • [26] Pre-transplantation risk factors for the development of sclerotic chronic GvHD after allogeneic HSCT: A multicentre retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Detrait, M.
    de la Tour, R. Peffault
    Yacoub-Agha, I.
    Crocchiolo, R.
    Vigouroux, S.
    Bay, J.
    Chevalier, P.
    Sobh, M.
    Morisset, S.
    Raus, N.
    Barraco, F.
    Labussiere, H.
    Tabrizi, R.
    Magro, L.
    Mohty, M.
    Milpied, N.
    Blaise, D.
    Socie, G.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S46 - S47
  • [27] Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Detrait, M. Y.
    Morisset, S.
    de Latour, R. Peffault
    Yakoub-Agha, I.
    Crocchiolo, R.
    Tabrizi, R.
    Bay, J-O
    Chevalier, P.
    Barraco, F.
    Raus, N.
    Vigouroux, S.
    Magro, L.
    Mohty, M.
    Milpied, N.
    Blaise, D.
    Socie, G.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 (02) : 253 - 258
  • [28] Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Societe Francaise des Cancers de l'Enfant and the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Paillard, C.
    Rochette, E.
    Lutz, P.
    Bertrand, Y.
    Michel, G.
    Bordigoni, P.
    Dalle, J. H.
    Rohrlich, P.
    Vannier, J. P.
    Perel, Y.
    Plantaz, D.
    Leverger, G.
    Sirvent, A.
    Dore, E.
    Isfan, F.
    Merlin, E.
    Pereira, B.
    Halle, P.
    Rabiau, N.
    Kanold, J.
    Demeocq, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1401 - 1408
  • [29] Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies
    Damaj, Gandhi
    Duhamel, Alain
    Robin, Marie
    Beguin, Yves
    Michallet, Mauricette
    Mohty, Mohamad
    Vigouroux, Stephane
    Bories, Pierre
    Garnier, Alice
    El Cheikh, Jean
    Bulabois, Claude-Eric
    Huynh, Anne
    Bay, Jacques-Olivier
    Legrand, Faeyzeh
    Deconinck, Eric
    Fegueux, Nathalie
    Clement, Laurence
    Dauriac, Charles
    Maillard, Natacha
    Cornillon, Jerome
    Ades, Lionel
    Guillerm, Gaelle
    Schmidt-Tanguy, Aline
    Marjanovic, Zora
    Park, Sophie
    Rubio, Marie-Therese
    Marolleau, Jean-Pierre
    Garnier, Federico
    Fenaux, Pierre
    Yakoub-Agha, Ibrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) : 4533 - 4540
  • [30] Reduced-intensity conditioning allogeneic stem cell transplantation for patients with high-risk multiple myeloma: a survey from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Mohty, M.
    Quoc-Hung, L.
    Nicolini, F. E.
    Garban, F.
    Esperou, H.
    Attal, M.
    Milpied, N.
    Lioure, B.
    Bordigoni, P.
    Yakoub-Agha, I.
    Bourhis, J. H.
    Rio, B.
    Deconninck, E.
    Renaud, M.
    Harousseau, J. L.
    Blaise, D.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S66 - S66